
Dulamet(200 mcg+5
Square Pharmaceuticals PLC.
Mometasone Furoate + Formoterol Fumarate is indicated for: FDA-approved indication Maintenance treatment of asthma in patients 5 years of age and older whose asthma is not adequately controlled on…
Mometasone Furoate + Formoterol Fumarate is indicated for:
Important: Mometasone Furoate + Formoterol Fumarate is not indicated for relief of acute bronchospasm or status asthmaticus and must not be used as a rescue inhaler; a separate short-acting bronchodilator should always be available for acute symptoms.
| Population | Recommended dose |
|---|---|
| Adults and adolescents 12 years and older | 2 inhalations of Mometasone Furoate + Formoterol Fumarate (100 mcg/5 mcg or 200 mcg/5 mcg strength, based on prior asthma therapy and severity) twice daily, morning and evening, approximately 12 hours apart. Maximum recommended dose: 2 inhalations of the 200 mcg/5 mcg strength twice daily. |
| Children 5 to 11 years | 2 inhalations of the lower (100 mcg/5 mcg) strength of Mometasone Furoate + Formoterol Fumarate twice daily; the higher strength is not established as safe/effective in this age group. |
The starting strength of Mometasone Furoate + Formoterol Fumarate is chosen based on the patient's current asthma controller therapy and disease severity; the dose should be titrated to the lowest effective strength once control is achieved, with periodic re-evaluation. Once-daily use or use as a rescue inhaler is not appropriate.
No dedicated dose adjustment of Mometasone Furoate + Formoterol Fumarate has been established for renal or hepatic impairment; use with caution and clinical monitoring, particularly in hepatic impairment where systemic corticosteroid exposure may be increased.
Common side effects of Mometasone Furoate + Formoterol Fumarate include:
Less common but serious effects can include paradoxical bronchospasm, hypersensitivity reactions, immunosuppression with increased infection risk, adrenal suppression/hypercorticism, cardiovascular effects (increased heart rate, blood pressure changes, arrhythmia), hypokalemia, hyperglycemia, reduced bone mineral density with long-term use, and effects on growth in children (see Precautions and Warnings, and Use in Special Populations).
Mometasone Furoate + Formoterol Fumarate is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.